Premium
Early Failure of Coronary Artery Bypass Grafts: An Albumin Cross‐Linked Glutaraldehyde (BioGlue) Related Complication
Author(s) -
Khan Habib,
Chaubey Sanjay,
Desai Jatin
Publication year - 2011
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/j.1540-8191.2011.01208.x
Subject(s) - medicine , glutaraldehyde , complication , albumin , artery , surgery , cardiology , pathology
Bioglue which constitutes albumin cross linked with glutaraldehyde (ACLG) produced by Cryolife, Inc, Kennesaw, GA was introduced as a better alternative to GRF glue with less tissue necrosis. We report a case of a 69‐year‐old male who developed stenosis of his saphenous vein and internal thoracic artery bypass grafts, requiring re‐do coronary artery bypass grafting. Both fibrotic narrowing were in close proximity to the site of Bioglue application and appears to be a reaction to the glue. The advent of ACLG has facilitated surgery; however, this case highlights a potential side effect, emphasizing the judicious use of this hemostatic agent in patients. (J Card Surg 2011;26:264‐266)